Abstract
Introduction
Metabolically healthy obesity may be a transient phenotype, but studies with long follow-up, especially covering late-life, are lacking. We describe conversions between cross-categories of body mass index (BMI) and metabolic health in 786 Swedish twins with up to 27 years of follow-up, from midlife to late-life.
Methods
Metabolic health was defined as the absence of metabolic syndrome (MetS). We first visualized conversions between BMI-metabolic health phenotypes in 100 individuals with measurements available at ages 50–64, 65–79, and ≥80. Next, we modeled conversion in metabolic health status by BMI category in the full sample using Cox proportional hazards regression.
Results
The proportion of individuals with MetS and with overweight or obesity increased with age. However, one-fifth maintained a metabolically healthy overweight or obesity across all three age categories. Among those metabolically healthy at baseline, 59% converted to MetS during follow-up. Conversions occurred 56% more often among individuals with metabolically healthy obesity, but not overweight, compared to normal weight. Among those with MetS at baseline, 60% regained metabolic health during follow-up, with no difference between BMI categories.
Conclusions
Conversions between metabolically healthy and unhealthy status occurred in both directions in all BMI categories. While conversions to MetS were more common among individuals with obesity, many individuals maintained or regained metabolic health during follow-up.
Similar content being viewed by others
Introduction
Metabolically healthy obesity (MHO) refers to a body mass index (BMI) above 30, but preserved metabolic health. There are no universal criteria to identify MHO, but metabolic health is often defined as the absence of metabolic syndrome (MetS) [1]. Although the risk of type 2 diabetes (T2D) and cardiovascular disease may be higher in MHO than in metabolically healthy normal weight, it is considerably lower than for metabolically unhealthy obesity [1]. However, MHO is considered a transient state, where individuals often develop MetS over time, followed by an increased risk of cardiovascular disease and T2D [2]. Few studies have examined conversions between BMI and metabolic health phenotypes over long time periods, and most cohorts have comparatively young ages at baseline [2]. As metabolism undergoes substantial changes during aging [3, 4] and BMI tend to decline at higher ages [5], it is not clear whether the stability or transiency of MHO in late-life is comparable to that of younger age groups. Therefore, we used longitudinal data from older adults with up to 27 years of follow-up, and aimed to: (1) describe conversions between cross-categories of BMI and metabolic health (BMI-MH) phenotypes from midlife (age 50–64), to early late-life (age 65–79), and late late-life (age ≥80), and (2) examine if conversions from metabolic health to MetS, or from MetS to metabolic health, are more common in some BMI categories.
Material and methods
The study population comprises 859 individuals from the Swedish Adoption/Twin Study of Aging (SATSA), a cohort study of same-sex twin pairs over the age of 50 who participated in up to 10 waves of data collections between 1986 and 2014 [6]. Each wave included an extensive questionnaire, interview, health examination, and blood sample collection, from where self-reported disease diagnoses and medication use and measures of height, weight, blood pressure, and blood biomarkers were available [6, 7]. Participants provided informed consent, and the study was approved by the Regional Ethical Review Board in Stockholm.
BMI was categorized (based on measured height and weight as kg/m2) into normal weight (18.5–24.9), overweight (25–29.9), and obesity (≥ 30). We used measured blood pressure, blood biomarkers, and self-reported disease diagnoses and medication use to define metabolic health as having ≤1 of the following (based on the NCEP ATP-III criteria [8] for MetS): hypertension (systolic or diastolic blood pressure ≥135 or ≥85 mmHg, respectively), hyperglycemia (fasting blood glucose levels ≥6.1 mmol/L, self-reported diagnosis of T2D, or self-reported use of T2D medications), hypertriglyceridemia (fasting triglyceride levels ≥1.70 mmol/L or self-reported use of lipid-lowering medications), and low high-density lipoprotein cholesterol (HDL-C levels <1.03 mmol/L in males and <1.30 in females, or self-reported use of lipid-lowering medications). Individuals were grouped into cross-categories of BMI-MH phenotypes: metabolically healthy normal weight (MHNw), overweight (MHOw), or obesity (MHOb), or metabolically unhealthy normal weight (MUNw), overweight (MUOw), or obesity (MUOb). To describe conversions between BMI-MH phenotypes across aging, we determined BMI-MH status in three age groups: 50–64, 65–79, and ≥80 years. When more than one measure was available in the same age group, that closest to age 57, 72, and 87 was selected for the respective age group. One hundred individuals had measures in all three age groups, and their conversions between BMI-MH phenotype across aging were visualized with the ggalluvial package [9] in R 4.0.5 [10]. To examine differences in conversion rates between metabolically healthy status and MetS by BMI category, we included 739 individuals with at least two measurements available. We modeled baseline BMI category as exposure and change in metabolic health status as the outcome in Cox proportional hazard regression with age as the underlying timescale, using STATA 17.0 [11]. Individuals were followed from the first measurement occasion to the first occasion when their metabolic health status differed from that at baseline, or to death or last participation (whichever occurred first). An interaction term was included to stratify by baseline metabolic health status so that the rate of conversion in metabolic health status was compared to those with the same metabolic health status and normal weight at baseline. To account for major confounders, all models were adjusted for sex, education (≤ 7 years versus >7 years, corresponding to basic versus more than basic education at the time), and smoking (never versus ever smoker). Robust standard errors were applied to account for non-independent observations (relatedness between twins).
Results
Description of conversions between BMI-MH categories
Figure 1 presents BMI-MH phenotype across time for the 100 individuals with measures taken in all three age categories, demonstrating that conversions are common in all directions across aging. The proportion of metabolically unhealthy individuals increased over time, as did the proportion of individuals with overweight or obesity. Twenty-eight percent of individuals with MHNw at baseline remained MHNw throughout the follow-up. Eighteen percent of those with MHOw at baseline remained MHOw across follow-up, and one of the three individuals with MHOb at baseline remained MHOb. In total, 30%, 50%, and 67% of those with MHNw, MHOw, and MHOb at age 50–64 had converted to MetS by age ≥80, respectively. On the other hand, of those with MUNw, MUOw, and MUOb at age 50–64, 67%, 47%, and 25%, respectively, had converted to being metabolically healthy by age ≥80.
Conversion between metabolically healthy status and MetS by BMI category
At first participation, the 739 individuals with at least two measurement occasions had a mean age of 63.3 (standard deviation (SD) 8.3, range 50–88); a mean BMI of 25.7 (SD 3.8, range 17.3–46.1); 32.9.% had MetS; 59.1% were women; 53.0% had less than 7 years of education; and 50.9% were ever-smokers. The mean follow-up time was 14.7 years (SD 7.6, range 2.9–27.0).
Table 1 shows BMI-MH phenotype at baseline, and metabolic health status at the end of follow-up. Conversions of metabolic health status occurred in both directions and all BMI categories. Among the 490 individuals who were metabolically healthy at baseline, 283 (58%) converted to MetS during follow-up. Compared to those with MHNw at baseline, conversions to MetS occurred at 56% higher rate among those with MHOb, but not MHOw, at baseline (Table 1). Among the 242 individuals with MetS at baseline, 146 (60%) regained metabolic health during follow-up, with no statistically significant difference between BMI groups (Table 1).
Discussion
In a sample of older adults with up to 27 years of follow-up, we first qualitatively described conversions between BMI-MH phenotypes from midlife (age 50–64) to early late-life (age 65–79) and then to late late-life (age 80 and above). In line with previous studies of adult samples [2, 12, 13], many individuals with MHOw or MHOb converted to MetS over time, but around one-fifth remained metabolically healthy from midlife and through early late-life and late late-life. Secondly, we tested for differences in the occurrence of conversions in metabolic health status between the different BMI categories. More than half of those who were metabolically healthy at baseline converted to MetS during the follow-up in all BMI categories. Individuals with MHOb at baseline were more likely to convert to MetS compared to those with MHNw at baseline, while no difference was seen between those with MHNw and MHOw. Interestingly, conversions from MetS to metabolically healthy BMI categories were also common, with no statistically significant difference between BMI categories.
The aging process is linked to major physiological changes, including changes in metabolism [3, 4] and BMI [5]. While transitions between BMI-MH phenotypes have been examined previously, most studies have focused on the stability of MHO in samples with a relatively young age at baseline [2]. Two previous studies have specifically modeled transitions between the six BMI-MH phenotypes, one followed 3512 women aged 50–79 over an average of six years [12] and the other 9742 men and women aged 20–60 over an average of 4 years [13]. In both studies, individuals with overweight or obesity were more likely to convert from metabolic health to MetS and less likely to convert from MetS to metabolic health, compared to those with normal weight. In the current study, we leveraged data from a well-characterized cohort with long follow-up, covering midlife to late late-life, to study conversions between BMI-MH phenotypes in older individuals over substantially longer periods than previously examined.
However, the small sample size limited our opportunities to examine the causes and consequences of conversions in metabolic health status or to apply more advanced models of transitions between BMI-MH phenotypes. It should also be mentioned that no consensus exists for how metabolic health should be defined [14]. While we used the NCEP ATP-III criteria [8] for MetS, the definition means that small changes in one of the constituents over time may lead to artificial changes in metabolic health status. Objective measures of BMI and metabolic health is a strength of the current study, but we also used self-reported information on diagnoses and the use of medications to define metabolic health, which may reduce the validity. In addition, the study sample consists of Swedish twins aged 50 or above, with a comparatively low proportion of MetS and obesity at baseline. As in most countries, the prevalence of obesity has risen substantially in Sweden during the past decades, from 9% in 1995 to 17% in 2017 [15], potentially limiting the generalizability of our findings to older adults today.
In conclusion, conversions between metabolic health and MetS were relatively common in both directions across all BMI categories during aging. Importantly, a substantial proportion of the sample maintained MHOw and MHOb throughout aging, and, in addition, a considerable proportion regained a metabolically healthy status. Taken together, this indicates that conversions between BMI-MH phenotypes seen in younger samples and over shorter follow-up periods [12, 13] continue across late-life. A better understanding of what predicts these conversions and the ability to maintain metabolic health in overweight and obesity could substantially improve obesity care and help promote and maintain metabolic health throughout life.
References
Tsatsoulis A, Paschou SA. Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences. Curr Obes Rep. 2020;9:109–120.
Zhang X, Zhu J, Kim JH, Sumerlin TS, Feng Q, Yu J. Metabolic health and adiposity transitions and risks of type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis. Diabetol Metab Syndr. 2023;15:60.
Houtkooper RH, Williams RW, Auwerx J. Metabolic networks of longevity. Cell. 2010;142:9–14.
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243–78.
Dahl AK, Reynolds CA, Fall T, Magnusson PK, Pedersen NL. Multifactorial analysis of changes in body mass index across the adult life course: a study with 65 years of follow-up. Int J Obes. 2014;38:1133–41.
Finkel D, Pedersen NL. Processing speed and longitudinal trajectories of change for cognitive abilities: the swedish adoption/twin study of aging. Aging Neuropsychol Cognit. 2010;11:325–45.
Hong Y, Pedersen NL, Brismar K, de Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet. 1997;60:143–52.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.
Brunson JC, Read QD. ggalluvial: AlluvialPlots in 'ggplot2'. R package version 0.12.5; 2023. http://corybrunson.github.io/ggalluvial/
R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2023.
StataCorp LJCS. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021.
Kabat GC, Wu WY, Bea JW, Chen C, Qi L, Stefanick ML, et al. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women. Int J Obes. 2017;41:170–7.
Zhang H, Tang X, Hu D, Li G, Song G. Transition patterns of metabolism-weight phenotypes over time: a longitudinal study using the multistate Markov model in China. Front Public Health. 2022;10:1026751.
Bluher M. Metabolically healthy obesity. Endocr Rev. 2020;41:1–16.
Hemmingsson E, Ekblom Ö, Kallings LV, Andersson G, Wallin P, Söderling J, et al. Prevalence and time trends of overweight, obesity and severe obesity in 447,925 Swedish adults, 1995–2017. Scand J Public Health. 2021;49:377–83.
Acknowledgements
This work was supported by the Strategic Research Program in Epidemiology at Karolinska Institutet; the Swedish Research Council for Health, Working Life and Welfare (2018-01201 and 2022-00672); the Swedish Research Council (2016-03081); Loo and Hans Osterman Foundation for Medical Research (2022-01222 and 2023-01855); Foundation for Geriatric Diseases at Karolinska Institutet (2022-01296 and 2023-01854); Karolinska Institutet’s Research Foundation (2022-01718); and the National Institutes of Health (R01 AG060470 and AG059329). The funding sources had no involvement in the current work. SATSA was supported by the National Institutes of Health (NIH; grants AG04563 and AG10175), the MacArthur Foundation Research Network on Successful Aging, the Swedish Research Council for Working Life and Social Research (FAS; Grants 97:0147:1B, 2009-0795), and the Swedish Research Council (825-2007-7460 and 825-2009-6141). We acknowledge the Swedish Twin Registry for access to data. The Swedish Twin Registry is managed by Karolinska Institutet and receives funding through the Swedish Research Council under the grant no. 2021-00180.
Funding
Open access funding provided by Karolinska Institute.
Author information
Authors and Affiliations
Contributions
IK conceived the study. PL, EO, and IK conducted the analyses and drafted the manuscript. PL, EO, YZ, DF, ADA, and IK all made substantial contributions to the study design and interpretation of data, and made critical revisions of the manuscript for important intellectual content.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ler, P., Ojalehto, E., Zhan, Y. et al. Conversions between metabolically unhealthy and healthy obesity from midlife to late-life. Int J Obes 48, 433–436 (2024). https://doi.org/10.1038/s41366-023-01425-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-023-01425-y
- Springer Nature Limited
This article is cited by
-
Metabolic obesity phenotypes and all-cause mortality among the Chinese oldest-old population: a prospective cohort study
International Journal of Obesity (2024)